168 related articles for article (PubMed ID: 38609357)
1. ANXA9 facilitates S100A4 and promotes breast cancer progression through modulating STAT3 pathway.
Zhou X; Zhao J; Yan T; Ye D; Wang Y; Zhou B; Liu D; Wang X; Zheng W; Zheng B; Qian F; Li Y; Li D; Fang L
Cell Death Dis; 2024 Apr; 15(4):260. PubMed ID: 38609357
[TBL] [Abstract][Full Text] [Related]
2. Exosome-derived ANXA9 functions as an oncogene in breast cancer.
Lu C; Zhan Y; Jiang Y; Liao J; Qiu Z
J Pathol Clin Res; 2023 Sep; 9(5):378-390. PubMed ID: 37294149
[TBL] [Abstract][Full Text] [Related]
3. Annexin A9 promotes cell proliferation by regulating the Wnt signaling pathway in colorectal cancer.
Lu X; Hu L; Mao J; Zhang S; Cai Y; Chen W
Hum Cell; 2023 Sep; 36(5):1729-1740. PubMed ID: 37349657
[TBL] [Abstract][Full Text] [Related]
4. High Expression of Annexin A9 Promotes Cell Proliferation and Migration in Gastric Cancer via the TGF-β Signaling Pathway.
Zhou Y; Qiu C; Wang T; Tao L; Zhang Z; Yao J
J Environ Pathol Toxicol Oncol; 2021; 40(3):87-94. PubMed ID: 34587407
[TBL] [Abstract][Full Text] [Related]
5. Exosomal S100A4 derived from highly metastatic hepatocellular carcinoma cells promotes metastasis by activating STAT3.
Sun H; Wang C; Hu B; Gao X; Zou T; Luo Q; Chen M; Fu Y; Sheng Y; Zhang K; Zheng Y; Ren X; Yan S; Geng Y; Yang L; Dong Q; Qin L
Signal Transduct Target Ther; 2021 May; 6(1):187. PubMed ID: 34035222
[TBL] [Abstract][Full Text] [Related]
6. S100A4 promotes invasion and angiogenesis in breast cancer MDA-MB-231 cells by upregulating matrix metalloproteinase-13.
Wang L; Wang X; Liang Y; Diao X; Chen Q
Acta Biochim Pol; 2012; 59(4):593-8. PubMed ID: 23162804
[TBL] [Abstract][Full Text] [Related]
7. Stanniocalcin 1 promotes lung metastasis of breast cancer by enhancing EGFR-ERK-S100A4 signaling.
Liu A; Li Y; Lu S; Cai C; Zou F; Meng X
Cell Death Dis; 2023 Jul; 14(7):395. PubMed ID: 37400459
[TBL] [Abstract][Full Text] [Related]
8. Annexin A9 promotes invasion and metastasis of colorectal cancer and predicts poor prognosis.
Yu S; Bian H; Gao X; Gui L
Int J Mol Med; 2018 Apr; 41(4):2185-2192. PubMed ID: 29393380
[TBL] [Abstract][Full Text] [Related]
9. miR-186-ANXA9 signaling inhibits tumorigenesis in breast cancer.
Wang Z; Zhou X; Deng X; Ye D; Liu D; Zhou B; Zheng W; Wang X; Wang Y; Borkhuu O; Fang L
Front Oncol; 2023; 13():1166666. PubMed ID: 37841425
[TBL] [Abstract][Full Text] [Related]
10. Relaxin reduces xenograft tumour growth of human MDA-MB-231 breast cancer cells.
Radestock Y; Hoang-Vu C; Hombach-Klonisch S
Breast Cancer Res; 2008; 10(4):R71. PubMed ID: 18718015
[TBL] [Abstract][Full Text] [Related]
11. Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH.
Gründker C; Bauerschmitz G; Schubert A; Emons G
Int J Oncol; 2016 Jun; 48(6):2713-21. PubMed ID: 27098123
[TBL] [Abstract][Full Text] [Related]
12. Exosome-transmitted S100A4 induces immunosuppression and non-small cell lung cancer development by activating STAT3.
Wu X; Zhang H; Jiang G; Peng M; Li C; Lu J; Jiang S; Yang X; Jiang Y
Clin Exp Immunol; 2022 Dec; 210(3):309-320. PubMed ID: 36370151
[TBL] [Abstract][Full Text] [Related]
13. Nuclear factor of activated T cells 5 maintained by Hotair suppression of miR-568 upregulates S100 calcium binding protein A4 to promote breast cancer metastasis.
Li JT; Wang LF; Zhao YL; Yang T; Li W; Zhao J; Yu F; Wang L; Meng YL; Liu NN; Zhu XS; Gao CF; Jia LT; Yang AG
Breast Cancer Res; 2014 Oct; 16(5):454. PubMed ID: 25311085
[TBL] [Abstract][Full Text] [Related]
14. Osterix promotes the migration and angiogenesis of breast cancer by upregulation of S100A4 expression.
Qu S; Wu J; Bao Q; Yao B; Duan R; Chen X; Li L; Yuan H; Jin Y; Ma C
J Cell Mol Med; 2019 Feb; 23(2):1116-1127. PubMed ID: 30450809
[TBL] [Abstract][Full Text] [Related]
15. RNA interference suppression of A100A4 reduces the growth and metastatic phenotype of human renal cancer cells via NF-kB-dependent MMP-2 and bcl-2 pathway.
Yang XC; Wang X; Luo L; Dong DH; Yu QC; Wang XS; Zhao K
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(12):1669-80. PubMed ID: 23832737
[TBL] [Abstract][Full Text] [Related]
16. S100A4 silencing suppresses proliferation, angiogenesis and invasion of thyroid cancer cells through downregulation of MMP-9 and VEGF.
Jia W; Gao XJ; Zhang ZD; Yang ZX; Zhang G
Eur Rev Med Pharmacol Sci; 2013 Jun; 17(11):1495-508. PubMed ID: 23771538
[TBL] [Abstract][Full Text] [Related]
17. S100A4 promotes pancreatic cancer progression through a dual signaling pathway mediated by Src and focal adhesion kinase.
Che P; Yang Y; Han X; Hu M; Sellers JC; Londono-Joshi AI; Cai GQ; Buchsbaum DJ; Christein JD; Tang Q; Chen D; Li Q; Grizzle WE; Lu YY; Ding Q
Sci Rep; 2015 Feb; 5():8453. PubMed ID: 25677816
[TBL] [Abstract][Full Text] [Related]
18. Tyr23 phosphorylation of Anxa2 enhances STAT3 activation and promotes proliferation and invasion of breast cancer cells.
Yuan J; Yang Y; Gao Z; Wang Z; Ji W; Song W; Zhang F; Niu R
Breast Cancer Res Treat; 2017 Jul; 164(2):327-340. PubMed ID: 28470457
[TBL] [Abstract][Full Text] [Related]
19. The oncoprotein HBXIP uses two pathways to up-regulate S100A4 in promotion of growth and migration of breast cancer cells.
Liu S; Li L; Zhang Y; Zhang Y; Zhao Y; You X; Lin Z; Zhang X; Ye L
J Biol Chem; 2012 Aug; 287(36):30228-39. PubMed ID: 22740693
[TBL] [Abstract][Full Text] [Related]
20. Hsa-miR-105-1 Regulates Cisplatin-Resistance in Ovarian Carcinoma Cells by Targeting ANXA9.
Kou X; Ding H; Li L; Chao H
Anal Cell Pathol (Amst); 2021; 2021():6662486. PubMed ID: 33680718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
